164 related articles for article (PubMed ID: 31797615)
1. Improving survival prediction using a novel feature selection and feature reduction framework based on the integration of clinical and molecular data.
Neums L; Meier R; Koestler DC; Thompson JA
Pac Symp Biocomput; 2020; 25():415-426. PubMed ID: 31797615
[TBL] [Abstract][Full Text] [Related]
2. Identification of clinically relevant features in hypertensive patients using penalized regression: a case study of cardiovascular events.
Garcia-Carretero R; Barquero-Perez O; Mora-Jimenez I; Soguero-Ruiz C; Goya-Esteban R; Ramos-Lopez J
Med Biol Eng Comput; 2019 Sep; 57(9):2011-2026. PubMed ID: 31346948
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening.
Jardillier R; Koca D; Chatelain F; Guyon L
BMC Cancer; 2022 Oct; 22(1):1045. PubMed ID: 36199072
[TBL] [Abstract][Full Text] [Related]
4. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
6. A convolutional neural network model for survival prediction based on prognosis-related cascaded Wx feature selection.
Yin Q; Chen W; Zhang C; Wei Z
Lab Invest; 2022 Oct; 102(10):1064-1074. PubMed ID: 35810236
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
8. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
9. Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.
Ternès N; Rotolo F; Michiels S
BMC Med Res Methodol; 2017 May; 17(1):83. PubMed ID: 28532387
[TBL] [Abstract][Full Text] [Related]
10. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
Liu C; Wang X; Genchev GZ; Lu H
Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
[TBL] [Abstract][Full Text] [Related]
12. Cancer survival classification using integrated data sets and intermediate information.
Kim S; Park T; Kon M
Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
[TBL] [Abstract][Full Text] [Related]
13. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Wang K; Li Y; Wang J; Chen R; Li J
Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
[TBL] [Abstract][Full Text] [Related]
14. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Cancer; 2021 Sep; 21(1):1053. PubMed ID: 34563154
[TBL] [Abstract][Full Text] [Related]
16. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
17. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
[TBL] [Abstract][Full Text] [Related]
18. A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model.
Sun N; Chu J; Hu W; Chen X; Yi N; Shen Y
Sci Rep; 2022 Jan; 12(1):27. PubMed ID: 34996932
[TBL] [Abstract][Full Text] [Related]
19. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
[TBL] [Abstract][Full Text] [Related]
20. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
